High levels of SRCIN1 mRNA are clinically relevant in NB patients, positively correlating with good prognosis and high survival rate, both OS and EFS, meaning that SRCIN1 expression correlates with decreased metastatic recurrences in NB patients. The gene discussed is SRCIN1; the disease is neuroblastoma.